Ticker
GOSSCompany Name
GOSSAMER BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 240.93M | $ 40.24M | 16.7% |
3/31/2025 | $ 280.59M | $ 124.59M | 44.4% |
12/31/2024 | $ 315.29M | $ 114.7M | 36.38% |
9/30/2024 | $ 350.88M | $ 105.32M | 30.02% |
6/30/2024 | $ 373.45M | $ 95.84M | 25.66% |
3/31/2024 | $ 259.36M | $ 0 | 0% |
12/31/2023 | $ 311.92M | $ 0 | 0% |
9/30/2023 | $ 347.93M | $ 0 | 0% |
6/30/2023 | $ 181.75M | $ 0 | 0% |
3/31/2023 | $ 219.91M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for GOSSAMER BIO INC is calculated as follows: GP [ $ 0 ] / Assets [ $ 584.18M ]
(=) GPA [ 0% ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.16% |
median | 15.35% |
std | 19.95% |